TELA Bio
TELA
68 hedge funds and large institutions have $93.4M invested in TELA Bio in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 15 increasing their positions, 23 reducing their positions, and 14 closing their positions.
620% more call options, than puts
Call options by funds: $36K | Put options by funds: $5K
71% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 14
17% more funds holding
Funds holding: 58 → 68 (+10)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
3.31% less ownership
Funds ownership: 83.92% → 80.61% (-3.3%)
20% less capital invested
Capital invested by funds: $117M → $93.4M (-$23.9M)
35% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$7.1M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$3.91M |
| 3 |
Millennium Management
New York
|
+$2.13M |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.27M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$15.6M |
| 2 |
BlackRock
New York
|
-$2.51M |
| 3 |
O
OrbiMed
New York
|
-$1.99M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.41M |
| 5 |
HWM
HighMark Wealth Management
St. Paul,
Minnesota
|
-$980K |
TELA Hedge Fund Activity: Q2 2024 in Review
68 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q2 2024, worth a combined $93.4M — down 20% from $117M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new TELA positions and 14 closed out — a net gain of 10 holders — while 15 added to existing stakes and 23 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $7.1M. The largest seller was First Light Asset Management, exiting entirely with an estimated $15.6M sold.
- 68 institutional investors held TELA Bio (TELA) as of Q2 2024, up from 58 in Q1 2024.
- Funds reported $93.4M of TELA Bio stock for Q2 2024, down 20% quarter-over-quarter.
- 24 funds opened new TELA Bio positions in Q2 2024 and 14 closed out, a net change of +10 holders.
- The largest TELA Bio buyer in Q2 2024 was Nantahala Capital Management, an estimated $7.1M added.
- The largest TELA Bio seller in Q2 2024 was First Light Asset Management, an estimated $15.6M sold.
Based on aggregated 13F filings for Q2 2024.